Annual Non Current Assets
$103.28 M
-$302.66 M-74.56%
December 31, 2023
Summary
- As of February 12, 2025, AGIO annual long term assets is $103.28 million, with the most recent change of -$302.66 million (-74.56%) on December 31, 2023.
- During the last 3 years, AGIO annual non current assets has fallen by -$112.99 million (-52.24%).
- AGIO annual non current assets is now -74.56% below its all-time high of $405.95 million, reached on December 31, 2022.
Performance
AGIO Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$717.61 M
+$576.67 M+409.17%
September 30, 2024
Summary
- As of February 12, 2025, AGIO quarterly long term assets is $717.61 million, with the most recent change of +$576.67 million (+409.17%) on September 30, 2024.
- Over the past year, AGIO quarterly non current assets has increased by +$576.67 million (+409.17%).
- AGIO quarterly non current assets is now at all-time high.
Performance
AGIO Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
AGIO Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -74.6% | +409.2% |
| 3 y3 years | -52.2% | +203.8% |
| 5 y5 years | -57.8% | +244.2% |
AGIO Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -74.6% | at low | at high | +594.8% |
| 5 y | 5-year | -74.6% | at low | at high | +594.8% |
| alltime | all time | -74.6% | +2558.5% | at high | >+9999.0% |
Agios Pharmaceuticals Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $717.61 M(+409.2%) |
| Jun 2024 | - | $140.94 M(-24.3%) |
| Mar 2024 | - | $186.08 M(+80.2%) |
| Dec 2023 | $833.84 M(+0.1%) | $103.28 M(-65.9%) |
| Sep 2023 | - | $302.91 M(-7.6%) |
| Jun 2023 | - | $327.91 M(-8.8%) |
| Mar 2023 | - | $359.64 M(-11.4%) |
| Dec 2022 | $832.77 M(-21.7%) | $405.95 M(+2.7%) |
| Sep 2022 | - | $395.38 M(+3.4%) |
| Jun 2022 | - | $382.46 M(+6.0%) |
| Mar 2022 | - | $360.71 M(-3.4%) |
| Dec 2021 | $1.06 B(+67.2%) | $373.50 M(+58.1%) |
| Sep 2021 | - | $236.21 M(+37.3%) |
| Jun 2021 | - | $172.04 M(+29.0%) |
| Mar 2021 | - | $133.32 M(-38.4%) |
| Dec 2020 | $636.68 M(+4.1%) | $216.28 M(-9.6%) |
| Sep 2020 | - | $239.36 M(+84.4%) |
| Jun 2020 | - | $129.79 M(-38.9%) |
| Mar 2020 | - | $212.46 M(-23.9%) |
| Dec 2019 | $611.70 M(-0.3%) | $279.04 M(+33.8%) |
| Sep 2019 | - | $208.47 M(-16.7%) |
| Jun 2019 | - | $250.16 M(-5.6%) |
| Mar 2019 | - | $265.04 M(+8.3%) |
| Dec 2018 | $613.78 M | $244.68 M(+4.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $233.54 M(-4.5%) |
| Jun 2018 | - | $244.45 M(+3.1%) |
| Mar 2018 | - | $237.13 M(+40.2%) |
| Dec 2017 | $445.26 M(-20.5%) | $169.14 M(+6.4%) |
| Sep 2017 | - | $158.89 M(+1.9%) |
| Jun 2017 | - | $155.92 M(+209.1%) |
| Mar 2017 | - | $50.45 M(-14.8%) |
| Dec 2016 | $559.89 M(+66.0%) | $59.20 M(-16.7%) |
| Sep 2016 | - | $71.10 M(-3.2%) |
| Jun 2016 | - | $73.44 M(+10.2%) |
| Mar 2016 | - | $66.65 M(-19.4%) |
| Dec 2015 | $337.33 M(-6.2%) | $82.74 M(+6.9%) |
| Sep 2015 | - | $77.43 M(-8.1%) |
| Jun 2015 | - | $84.23 M(-23.6%) |
| Mar 2015 | - | $110.19 M(-16.7%) |
| Dec 2014 | $359.55 M(+111.8%) | $132.36 M(+500.3%) |
| Sep 2014 | - | $22.05 M(-17.9%) |
| Jun 2014 | - | $26.87 M(+183.0%) |
| Mar 2014 | - | $9.49 M(-69.8%) |
| Dec 2013 | $169.75 M(+30.4%) | $31.46 M(+55.3%) |
| Sep 2013 | - | $20.25 M(+132.3%) |
| Jun 2013 | - | $8.72 M(+16.2%) |
| Mar 2013 | - | $7.51 M(+9.4%) |
| Dec 2012 | $130.14 M(-31.7%) | $6.86 M |
| Dec 2011 | $190.59 M | - |
FAQ
- What is Agios Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals annual non current assets year-on-year change?
- What is Agios Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals quarterly non current assets year-on-year change?
What is Agios Pharmaceuticals annual long term assets?
The current annual non current assets of AGIO is $103.28 M
What is the all time high annual non current assets for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high annual long term assets is $405.95 M
What is Agios Pharmaceuticals annual non current assets year-on-year change?
Over the past year, AGIO annual long term assets has changed by -$302.66 M (-74.56%)
What is Agios Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of AGIO is $717.61 M
What is the all time high quarterly non current assets for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high quarterly long term assets is $717.61 M
What is Agios Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, AGIO quarterly long term assets has changed by +$576.67 M (+409.17%)